What is the main business of Polisplint?

The main business activity of Polisplint focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 24, 2024.

Where is the headquarters located?

The headquarters is located at: Chmielna 73B, 00-801 Warszawa.

Who is on the management board?

The management board consists of: Artur Mosak (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from December 24, 2024 to December 31, 2025.

What was the revenue?

The company reported a revenue of USD 1,053 in 2025.

No, in 2025 the company was not profitable, reporting a net loss of USD 78,138.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to USD 34,921 in 2025, representing 44% of all operating expenses.

Polisplintsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2024-12-24

Share capital

5,000.00 PLN

Activity description

Polisplint develops a ready-to-use orthopedic splint for immobilizing upper and lower limbs, consisting of a carrier impregnated with a water-curing prepolymer and a protective layer. The product is intended for hospitals, emergency medical services, sports injuries, the military and rescue services.

Registered address

Chmielna 73B/14, 00-801 Warszawa, Poland

Website

polisplint.pl

Electronic delivery address

AE:PL-57950-97475-SWSWR-14

Financials

Filing timeliness

1 of 1 financial statements was filed late (for 2025, 23 days late).

202507/08/2026

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 1.05kMedianUSD 55.24kAverageUSD 2.71m

Net profit

This companyUSD -78.14kMedianUSD -1.27kAverageUSD -91.85k

Operating costs

This companyUSD 79.15kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 36.56kMedianUSD 133.19kAverageUSD 3.03m

Industry

Offer

Orthopedic splint
Immobilization dressing
Supporting bandage

Website technology

Online shop

WooCommerce

Website

WordPress
Divi

Authorized Representatives

Rafał Grabowski – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Rafał Grabowskiage 39	51	$688.82	51%
Szymon Kupajage 53	49	$661.80	49%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2025-03-27.

ING Bank Śląski
13 1050 1823 1000 0090 8458 3252

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Jan 23, 2025	De minimis aid (in accordance with Commission Regulation 2023/2831)	––	Fundacja Polska Przedsiębiorcza

Competitors

	Name	Revenue	Website
	Poltisssp. z o.o.	$3,843.72	poltiss.com

Change history

Date	Event
2026-08-04	Address change (Lublin → Chmielna 73b/14, 00-801, Warszawa)
2024-12-24	Entered in the register

FAQ

Last updated: 2026-10-04